{"entity":{"id":"shankar-siva","kind":"person","name":"Shankar Siva","aka":[],"tldr":"Radiation oncologist who established stereotactic radiotherapy as a non-surgical option for primary kidney cancer.","summary":"Shankar Siva led the FASTRACK trials and the International Radiosurgery Oncology Consortium for Kidney pooled analyses showing stereotactic ablative body radiotherapy achieves near-complete local control of primary renal cell carcinoma in patients unfit for surgery, and leads TROG trials of SABR in oligometastatic prostate and lung cancer and of radiotherapy-immunotherapy combinations. He chairs the TROG genitourinary group.","asOf":"2026-09-10","links":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Siva%20S%5BAuthor%5D%20stereotactic%20kidney"}],"tags":["radiotherapy","sbrt","kidney","australia"],"related":[],"cancers":["rcc","prostate"],"sections":[],"technologies":["sbrt"],"targets":[],"drugs":[],"companies":["trog"],"institutions":["peter-mac"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Professor and Director of Radiation Oncology Research, Peter MacCallum Cancer Centre","institutionId":"peter-mac","specialisms":["Stereotactic radiotherapy","Kidney cancer","Oligometastatic disease","Radiotherapy-immunotherapy combinations"],"profiles":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Siva%20S%5BAuthor%5D%20stereotactic%20kidney"}],"papers":[{"title":"Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial","journal":"Lancet Oncology","year":2024,"doi":"10.1016/S1470-2045(24)00020-2"},{"title":"Five-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK","journal":"Lancet Oncology","year":2022,"doi":"10.1016/S1470-2045(22)00656-8"}]},"route":"/people/shankar-siva/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"},{"id":"rcc","kind":"cancer","name":"Renal cell carcinoma","route":"/cancers/rcc/"}],"technology":[{"id":"sbrt","kind":"technology","name":"SBRT / SABR (stereotactic radiotherapy)","route":"/technologies/sbrt/"}],"company":[{"id":"trog","kind":"company","name":"TROG Cancer Research","route":"/companies/trog/"}],"institution":[{"id":"peter-mac","kind":"institution","name":"Peter MacCallum Cancer Centre","route":"/institutions/peter-mac/"}]}}